Market Overview

ProQR Therapeutics (NASDAQ: PRQR)

4.50 -0.50 (-10.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2020
Pre-Market
EPS:
REV:




Q3 2020
Pre-Market
EPS:
REV:
-0.34
530K



Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
-0.41
474.24K



Q4 2019
Pre-Market
EPS:
REV:
-0.38
1.52M
-0.35
-0.43
470.64K
-22.86%
Q3 2019
Pre-Market
EPS:
REV:
-0.18
3.402M
-0.38
880K
-0.34
530K
10.53%
-39.77%
Q2 2019
Pre-Market
EPS:
REV:
-0.27
1.126M

-0.34
630.56K

Q1 2019
Pre-Market
EPS:
REV:
-0.40
593.81K
-0.41
700K
-0.41
474.24K
0%
-32.25%
Q4 2018
Pre-Market
EPS:
REV:
-0.48
623.42K
-0.26
1.92M
-0.38
1.52M
46.15%
-20.83%
Q3 2018
Pre-Market
EPS:
REV:
-0.49
381.42K
-0.35
660K
-0.21
3.402M
-40%
415.45%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!